Gary Greenberg on Depression, Addiction, and the Brain

Episode Summary

Executive Summary: Gary Greenberg argues that psychiatry often turns moral, philosophical, and social judgments into “scientific” medical diagnoses to expand treatment, authority, and market share. Using brain death, alcoholism, and depression, he says many psychiatric categories are shaped by context and incentives, while drugs often alter consciousness and behavior more than they specifically treat discrete diseases.

Main Topics: Medicine, science, and moral authority (Priority: 5/5): Greenberg argues that modern medicine borrows science’s prestige to settle value-laden questions about life, death, suffering, and normality, often disguising philosophical choices as objective facts. Brain death and organ transplantation (Priority: 5/5): He uses brain death as a key example of a medical definition created to facilitate organ transplants, noting that redefining death as brain failure was a practical and moral choice presented as biological truth. Alcoholism, addiction, and the disease model (Priority: 5/5): Greenberg traces alcoholism’s reclassification from vice to disease to a public-relations strategy that benefited physicians and AA, while arguing the biological basis of addiction remains unsettled and context matters greatly. Depression diagnosis and pharmaceutical incentives (Priority: 5/5): He contends that modern depression diagnosis is broad, subjective, and influenced by drug companies, enabling more people to be labeled ill and treated pharmacologically even when distress may be situational. What antidepressants actually do (Priority: 4/5): Greenberg distinguishes between drugs’ effects on mood, consciousness, and personality versus their claimed role as treatments for a clearly defined disease, arguing efficacy against placebo is limited and effects are more complex. Szasz, Kaczynski, and the power of psychiatric labeling (Priority: 4/5): He contrasts his view with Thomas Szasz, then uses Ted Kaczynski’s case to show how psychiatric labels can redirect moral and legal judgment into medicalized categories. The expanding role of psychiatrists (Priority: 4/5): Russ Roberts underscores, and Greenberg agrees, that doctors increasingly define more of life’s problems as medical matters, raising concerns about power, dependency, and the shrinking space for ordinary suffering.

Key Arguments: Science has become a substitute source of truth after religion, but in medicine it is often used to mask underlying moral and philosophical decisions. Brain death was not simply discovered; it was defined in a way that helped solve an organ-transplant problem by allowing organs to be removed sooner. The disease model of alcoholism became dominant largely because doctors and a recovering alcoholic PR strategist sold it as a way to gain medical authority over addiction treatment. There is evidence of biological involvement in addiction and depression, but not enough to justify simple one-cause biological explanations. Addiction and depression are deeply shaped by context, suffering, and social environment; reducing them to brain chemistry misses much of the reality. Psychiatric diagnosis relies on subjective, context-sensitive questions, yet is presented as objective and medical, creating an illusion of precision. Antidepressants may help some people, especially more severely depressed patients, but they often outperform placebo only modestly and may primarily change consciousness, personality, or self-experience. Calling suffering a disease can reduce stigma and open access to treatment, but it can also reduce responsibility, centralize power, and medicalize normal human experiences. The boundary between grief and illness is especially problematic; bereavement historically served as an exception, but that exception is being removed. Szasz wanted a firm line between disease and problems of living; Greenberg argues that such a line is historically unstable and may be impossible to draw cleanly.

Data Points: Date of episode: September 16th, 2010 - Opening metadata for the EconTalk conversation Brain death origin: Late 1960s - Greenberg says the brain-death definition was developed during the rise of organ transplantation Prohibition era: Early 1930s repeal - He describes how alcoholism treatment and public attitudes changed after Prohibition ended Alcohol studies PR paper: End of the 1930s - A recovering alcoholic public-relations expert helped doctors market alcoholism as a disease Clinical trial length: About 8 weeks - Greenberg describes his participation in a depression trial using omega-3 fatty acids or placebo Trial visits: Every 2 weeks - He returned periodically for repeated symptom assessments during the study Depression diagnostic criteria: 9 symptoms - He explains the DSM-style symptom checklist used to diagnose depression Bereavement exception duration: 2 months - He notes the DSM allowed grief-related symptoms to be excluded from depression if they did not persist beyond this period Drug response in severe depression: Slightly better than placebo; around 60% in the right patient - Greenberg says antidepressants have limited but sometimes meaningful benefits in severely depressed people Gene association evidence: Small percentage of cases accounted for by particular variants - He says genome-wide association studies have not produced a simple genetic explanation for alcoholism Brain complexity: About 100 trillion connections - Used to emphasize why single-pathway explanations for depression are unlikely to be sufficient DSM revision: Ongoing at the time of the interview - He argues that psychiatric categories remain unresolved and contested

Pivotal Quotes: "Death is this idea that if your brain has been destroyed, even if your heart is still beating and you're still breathing... you're dead." — Gary Greenberg: Explaining how brain death redefined the boundary between life and death "The disease of alcoholism was invented by a public relations guy." — Gary Greenberg: Summarizing his historical critique of the alcoholism-as-disease model "The drugs do plenty, but there's no financial interest in figuring out what it is." — Gary Greenberg: On antidepressants affecting consciousness and personality beyond their advertised role

Implications: Listeners should be cautious about treating psychiatric labels as settled science. The conversation suggests medicine often encodes values and incentives, and future debates should focus less on simple disease narratives and more on context, meaning, and limited but real drug effects.